CatalYm GmbH

Quick facts

Phase 2 pipeline

• Carboplatin AUC 5 · Oncology
  Alkylating agent that interferes with DNA replication

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• CatalYm GmbH portfolio CI brief
• CatalYm GmbH pipeline updates RSS